Actively Recruiting
Concurrent OCT and FFR-guided PCI in CAD
Led by Korea University Guro Hospital · Updated on 2023-12-27
700
Participants Needed
1
Research Sites
317 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.
CONDITIONS
Official Title
Concurrent OCT and FFR-guided PCI in CAD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 19 years old
- Undergoing coronary stent implantation for stable angina or acute coronary syndrome
- Provided informed consent to participate
You will not qualify if you...
- History of increased bleeding tendencies or hematologic disorders
- Presented with refractory cardiogenic shock
- History of stent thrombosis
- Expected life expectancy less than 1 year
- Left ventricular ejection fraction less than 20%
- Women who are breastfeeding, pregnant, or planning pregnancy
- Deemed unsuitable for participation by the investigator
- Unwilling to participate in the clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Korea University Guro Hospital
Seoul, South Korea, 08308
Actively Recruiting
Research Team
D
Dong Oh Kang, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here